ALS drug will be pulled from US market after study showed patients didn't benefit

  • 📰 9NEWS
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 63%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

The telethon runs from 5 a.m. to 7 p.m. Thursday, April 4. Call 303-577-2080 to raise funds to send Colorado veterans on the trip of a lifetime.

The drug’s failure is a major disappointment for ALS patients and advocates who pressed the FDA to approve it back in 2022.MATTHEW PERRONE WASHINGTON — The maker of a drug for Lou Gehrig’s disease that recently said Thursday it will pull the medicine from the market, acknowledging it didn't help patients with the deadly neurological condition.

“While this is a difficult moment for the ALS community, we reached this path forward in partnership with the stakeholders who will be impacted and in line with our steadfast commitment to people living with ALS," company co-founders said in a statement. Patients already taking the therapy who wish to continue will be able to enroll in a program to receive it for free.

 

コメントありがとうございます。コメントは審査後に公開されます。
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 238. in JP

日本 最新ニュース, 日本 見出し